Jochen Klaus Maria Lennerz, Ph.D., M.D.
This page shows the publications co-authored by Jochen Lennerz and Lori Wirth.
Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma. Thyroid. 2020 09; 30(9):1384-1389.
Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. Oncologist. 2019 10; 24(10):1356-1367.
ROS1 Rearrangement in Thyroid Cancer. Thyroid. 2016 06; 26(6):794-7.
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Ann Oncol. 2020 12; 31(12):1725-1733.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.